Enteroviral infections in children with malignant disease: a 5-year study in a single institution

Maria A Moschovi1, Katerina Katsibardi, Maria Theodoridou

  • 1Hematology-Oncology Unit, First Department of Pediatrics, University of Athens, Aghia Sophia Children's Hospital, Thivon & Levadias Ave, Athens 11527, Greece. mmoschov@med.uoa.gr <mmoschov@med.uoa.gr>

The Journal of Infection
|September 9, 2006
PubMed

Insights

Enteroviral infections pose severe risks to children with malignancy, particularly those with lymphoid cancers. High-dose intravenous immunoglobulin (IVIG) showed promise in reducing viral load, suggesting potential for improved outcomes with early intervention.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Virology

Background:

  • Enteroviral infections can present with severe clinical manifestations in immunocompromised pediatric patients.
  • Children undergoing cancer treatment are at increased risk for opportunistic infections.

Purpose of the Study:

  • To investigate the clinical presentation, severity, and outcomes of enteroviral infections in pediatric cancer patients.
  • To evaluate the efficacy of treatments such as intravenous immunoglobulin (IVIG) and pleconaril.

Main Methods:

  • Retrospective assessment of enteroviral infections in a University Pediatric Hematology-Oncology Unit over 5 years.
  • Utilized RT-PCR, immunohistochemistry, and indirect immunofluorescence assay for viral detection and typing.

Main Results:

  • Enteroviral infection was documented in 55 of 104 evaluated children.
  • Severe manifestations (encephalitis, cardiac involvement, hemophagocytic syndrome) occurred in 20% of infected children.
  • Children with lymphoid malignancy had a higher incidence (87%) of enteroviral infections compared to those with solid tumors (13%).
  • High-dose IVIG led to early negative viral load, but the overall infection-related fatality rate was 14.5%.

Conclusions:

  • Enteroviruses cause severe and potentially lethal disease in pediatric cancer patients, especially those with lymphoid malignancies.
  • High-dose IVIG administration appears beneficial in clearing viremia.
  • Early therapeutic intervention with high-dose IVIG may improve patient outcomes.
Abstract

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...